Literature DB >> 6420927

Glucocorticoids inhibit plasminogen activator production by endothelial cells.

W E Laug.   

Abstract

Confluent cultures of bovine aortic endothelial cells (BEC) were found to secrete both tissue type plasminogen activator (t-PA) and urokinase type plasminogen activator (u-PA). Exposure of the cultures to increasing concentrations of dexamethasone resulted in a time and concentration dependent inhibition of cellular and secreted u-PA. Complete inhibition of u-PA production and secretion was found at dexamethasone concentrations of 10(-8) molar or higher. Several distinct PA forms with molecular weights ranging from 10,000-20,000 to greater than 200,000 were found in the conditioned medium of untreated BEC cultures. After addition of dexamethasone (10(-7) molar) to the culture medium the PAs with molecular weights of 117,000, 58,000, 47,000, were absent suggesting that they were u-PAs, whereas the PAs with molecular weights of greater than 200,000 and 75,000 remained unchanged suggesting their t-PA origins. The PAs with lower molecular weights of 35,000, 28,000 and 10,000 to 20,000 were most likely generated from the higher molecular weight forms by limited proteolysis since they were absent when the medium was conditioned in the presence of the protease inhibitor Trasylol. The two PA types may therefore be independently regulated in BEC.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6420927

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Effect of a Change in the Sleep/Wake Cycle on the Diurnal Variation of Fibrinolytic Parameters.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-05       Impact factor: 2.300

2.  Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.

Authors:  Darko Kastelan; Tina Dusek; Ivana Kraljevic; Ozren Polasek; Zlatko Giljevic; Mirsala Solak; Silva Zupancic Salek; Jozo Jelcic; Izet Aganovic; Mirko Korsic
Journal:  Endocrine       Date:  2009-04-21       Impact factor: 3.633

Review 3.  Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk.

Authors:  Johannes M M Boots; Maarten H L Christiaans; Johannes P van Hooff
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Plasminogen activator activity in differentiating rat myoblasts.

Authors:  M Mayer; Z Finci; M Chaouat; S Sasson
Journal:  Mol Cell Biochem       Date:  1986-02       Impact factor: 3.396

5.  Suppression of the degradation of recombinant human apolipoprotein E by a protease inhibitor obtained from fetal bovine serum in serum-free culture.

Authors:  T Shimomura; T Honda; C Oouchi; J Kondo; K Nagaike
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

Review 6.  Prognostic significance of proteolytic enzymes in human brain tumors.

Authors:  A K Bindal; M Hammoud; W M Shi; S Z Wu; R Sawaya; J S Rao
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Variable response of tissue parameters of the fibrinolytic system to unilateral or bilateral adrenalectomy and unilateral or bilateral adrenal demedullation.

Authors:  A Smokovitis; N Kokolis; C Rekkas; T Ploumis
Journal:  J Endocrinol Invest       Date:  1991-11       Impact factor: 4.256

8.  Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.

Authors:  L M Fatti; B Bottasso; C Invitti; R Coppola; F Cavagnini; P M Mannucci
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 5.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.